Cargando…
Novel agents and evolving strategies in myelofibrotive neoplasm: an update from 2022 ASH annual conference
Myelofibrosis (MF) is a disorder characterized by the proliferation of myeloid precursors, commonly due to overactive JAK signaling. The discovery of the JAK2(V617F) mutation and subsequent development of JAK inhibitors (JAKi) results in reduced spleen size, improved symptom, and enhanced survival i...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182587/ https://www.ncbi.nlm.nih.gov/pubmed/37173704 http://dx.doi.org/10.1186/s13045-023-01446-0 |